Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #1

    LRIG New England, March 23rd: Amgen, Broad & Ion Torrent speaking

    Laboratory Robots Interest Group (LRIG) New England presents a discussion on Next Gen Sequencing

    Sponsored by: Ion Torrent

    Wednesday March 23rd, 2011
    AstraZeneca
    35 Gatehouse Lane
    Waltham, MA 02451
    REGISTER HERE

    5:00pm Social Hour with appetizers and drinks

    6:00pm Opening Statements

    6:10pm
    Impact of Next Gen Sequencing in biomarker assessment
    Sunita Badola
    Scientist
    Amgen Inc.

    7:10pm Data processing and analysis of genetic variation using next-generation sequencing
    Mark DePristo
    Manager of Medical and Population Genetic Analysis
    Broad Institute of MIT and Harvard

    7:40pm The Ion Torrent Personal Genome Machine for Semiconductor Sequencing – The first PostLightTM sequencing platform delivering rapid, accurate, and low-cost sequence for all laboratories
    Jason Affourtit
    Director, Field Applications Support
    Ion Torrent Systems, part of Life Technologies

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...